Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Blue Apron

FaZe Holdings Inc

Party City Holdco

Short interest penny stocks to watch right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 4 Short Squeeze Stocks To Watch Today

PHILADELPHIA--(BUSINESS WIRE)--With flu and respiratory illnesses expected to increase during fall and winter months, Rite Aid (NYSE: RAD) is making diagnostic testing easier for Michigan customers with rapid point-of-care testing now available at all stores throughout the state.

Rite Aid Offers Point-of-Care Testing Throughout Michigan

PHILADELPHIA--(BUSINESS WIRE)--Following FDA authorization and new CDC recommendations, Rite Aid (NYSE: RAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering updated boosters of the Pfizer-BioNTech and Moderna COVID-19 vaccines for children ages five years and older.

Scheduling for COVID-19 Updated Boosters for Children Ages Five and Older Now Available at Rite Aid and Bartell Drug Locations

PHILADELPHIA--(BUSINESS WIRE)--Halloween is lurking around the corner and in honor of the spooky season, Rite Aid has released surprising findings on consumers' favorite trick-or-treating novelties and seasonal shopping habits.

Rite Aid Releases ‘Trick-or-Trivia' on Candy Consumptions

Bio-Rad Laboratories

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24%.

Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?

Google Cloud technologies to help Rite Aid make its pharmacies more personalized, data-driven, and resilient PHILADELPHIA and SUNNYVALE, Calif. , Oct. 11, 2022 /PRNewswire/ -- Rite Aid (NYSE: RAD) and Google Cloud today announced a new, multi-year technology partnership that will help Rite Aid realize its vision of a modern pharmacy.

Rite Aid and Google Cloud Partner to Modernize Pharmacy Operations and Enhance the Online Customer Experience

New York, New York--(Newsfile Corp. - October 8, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Rite Aid and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rite Aid Corporation - RAD

OAKLAND, Calif.--(BUSINESS WIRE)---- $RAD #RAD--Gibbs Law Group is investigating potential claims on behalf of Rite Aid (RAD) Investors.

Lost Money in Rite Aid Corp.?

Rite Aid is contemplating putting all store goods in showcases in New York City in an effort to curb retail theft, according to a report from Fox 5 New York.

Rite Aid may place all store items in showcases due to theft in New York City

Will Rite Aid stock ever recover? Unless Rite Aid can improve its revenue, the best advice for investors may involve staying away from the stock.

Rite-Aid Sings a Familiar Tune That Investors Don't Want to Hear

Rite Aid said losses from inventory "shrink," or theft, increased by $5 million.

Rite Aid bosses blame out-of-control NYC shoplifting for $5M revenue hit

Rite Aid's chief retail officer addressed the difficulty facing the chain's NYC stories concerning shoplifting.

Rite Aid exec: Impossible to stop NYC store thefts

Rite Aid (RAD) posts lower Q2 revenues from the year-ago fiscal quarter's level due to sluggishness in both the Retail Pharmacy and Pharmacy Services segments.

Rite Aid (RAD) Q2 Loss Wider Than Expected, Revenues Beat

The company's retail decline was evident with an unimpressive quarterly report.

Why Rite-Aid Stock Fell 28% on Thursday

The pharmacy retailer's latest quarterly update disappointed investors.

Why Rite Aid Stock Is Plunging Today

Rite Aid Corporation (NYSE:RAD ) Q2 2023 Earnings Conference Call September 29, 2022 8:30 AM ET Company Participants Byron Purcell - VP, IR & Treasurer Heyward Donigan - President & CEO Matt Schroeder - EVP & CFO Andre Persaud - EVP & CRO Chris DuPaul - COO, Elixir Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - J.P. Morgan Chase George Hill - Deutsche Bank William Reuter - Bank of America Securities Karru Martinson - Jefferies Carla Casella - J.P.

Rite Aid Corporation's (RAD) Q2 2023 Earnings Call Transcript

Rite Aid Corporation (NYSE: RAD) tanked nearly 30% on Thursday after the drugstore chain reported bigger than expected loss for its fiscal second quarter and lowered guidance for the full year. Rite Aid Q2 earnings snapshot Lost $331.3 million versus the year-ago figure of $100.3 million Per-share loss climbed significantly from $1.86 to $6.

Rite Aid stock crashed 30% on Thursday: this is why

Source: Michael Gordon / Shutterstock.com Rite Aid (NYSE: RAD ) stock is falling on Thursday after the pharmacy company updated its guidance for the fiscal full year of 2023. That new guidance starts with the company expecting a net loss of $520.3 million to $477.3 million for the year.

Rite Aid (RAD) Stock Tumbles After Cutting Full-Year Guidance

Rite Aid reported a quarterly loss of more than $300 million as fewer customers came to the drugstore for Covid-19 tests and vaccines.

Rite Aid Losses Hit $311 Million As Inflation Pressures Rise

Rite Aid (RAD) delivered earnings and revenue surprises of -36.96% and 0.66%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Reports Q2 Loss, Tops Revenue Estimates

Rite Aid Corp. stock RAD, +7.16% slid 11% in premarket trade Thursday, after the pharmacy retail chain posted a wider-than-expected loss for its fiscal second quarter as it booked goodwill impairment charges on its pharmacy services segment as well as charges for higher facility exit and store closures. The company had a net loss of $331.3 million, or $6.07 a share.

Rite Aid stock slides 11% premarket after company posts bigger-than-expected Q2 loss

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its second fiscal quarter ended August 27, 2022. “We've made good progress on key initiatives during the quarter: driving prescription growth and market share, improving operating margins at Elixir and achieving reductions in SG&A expenses across our business,” said Heyward Donigan, president and CEO. “As we look to the second half of the year, we expect continued pressure on consumer spendi

Rite Aid Corporation Reports Fiscal 2023 Second Quarter Results

Bed Bath & Beyond

CarMax

The three major U.S. equity indexes closed lower again Monday. The Dow Jones industrials ended the day down 1.11%, the S&P 500 closed lower by 1.03%,and the S&P 500 retreated 0.6%.

Earnings Previews: Bed Bath & Beyond, CarMax, Rite Aid

Rite Aid's (RAD) Q2 performance is likely to have been hurt by low COVID vaccine and testing demand. Strength in PBM, digital expansion and higher non-COVID prescriptions are expected to have aided.

Factors Likely to Decide Rite Aid's (RAD) Fate in Q2 Earnings

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced that Steve Bixler, vice president of financial accounting, will become the new chief accounting officer effective Jan. 13, 2023, following the retirement of Brian Hoover who has served in the role for the last three years during his 27 years with Rite Aid. Bixler will report to Chief Financial Officer Matt Schroeder. “We look forward to a seamless transition and the leadership Steve will bring as we continue our journey toward

News for Rite Aid Stock (RAD)